Candel Therapeutics Inc

NAS:CADL (USA)  
$ 8.63 -0.12 (-1.37%) 10:08 PM EST
At Loss
Market Cap:
$ 389.16M
Enterprise V:
$ 388.63M
Volume:
2.64M
Avg Vol (2M):
4.56M
Trade In:
Volume:
2.64M
At Loss
Avg Vol (2M):
4.56M

Business Description

Candel Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US1374041093
Description
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Name Current Vs Industry Vs History
Cash-To-Debt 1.03
Equity-to-Asset -0.71
Debt-to-Equity -1.05
Debt-to-EBITDA -0.33
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -19.3
3-Year EPS without NRI Growth Rate -24.3
3-Year FCF Growth Rate -28.6
Name Current Vs Industry Vs History
5-Day RSI 61.91
9-Day RSI 61.96
14-Day RSI 61.37
6-1 Month Momentum % -16.56
12-1 Month Momentum % 350

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.18
Quick Ratio 1.18
Cash Ratio 1.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.8
Shareholder Yield % -1.16

Profitability Rank

Name Current Vs Industry Vs History
ROE % -1580.16
ROA % -153.09
ROIC % -262.71
ROC (Joel Greenblatt) % -1326.29
ROCE % -241.48

Financials (Next Earnings Date:2025-03-28 Est.)

CADL's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CADL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Candel Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.73
Beta -0.85
Volatility % 354.68
14-Day RSI 61.37
14-Day ATR ($) 1.542227
20-Day SMA ($) 5.9785
12-1 Month Momentum % 350
52-Week Range ($) 1.1 - 14.6
Shares Outstanding (Mil) 44.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Candel Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Candel Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Candel Therapeutics Inc Frequently Asked Questions

What is Candel Therapeutics Inc(CADL)'s stock price today?
The current price of CADL is $8.63. The 52 week high of CADL is $14.60 and 52 week low is $1.10.
When is next earnings date of Candel Therapeutics Inc(CADL)?
The next earnings date of Candel Therapeutics Inc(CADL) is 2025-03-28 Est..
Does Candel Therapeutics Inc(CADL) pay dividends? If so, how much?
Candel Therapeutics Inc(CADL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1